CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis.
Rocco JM, Oved JH, Patel RJ, Herskovits AZ, Nair N, Shakoory B, Robertson T, Dileo R, Jacobs MW, Zerbe C, Gordon R, Ombrello MJ, Ombrello AK, Shah NN, Dimitrova D, Kanakry JA, Zelenetz AD, Moskowitz AJ, Stuver RN, Epstein-Peterson ZD, Ghione P, Mead E, Shahid Z, Giralt SA, Raj SS, Park JH, Maillard I, Geyer MB, Xiao W, Dogan A, Lim MS, Zwicker JI, Mones JV, Parameswaran R, Banaszak LG, Geller S, Santomasso BD, Shouval R, Curran KJ, Delmonte OM, Notarangelo LD, Cohen JI, Holland SM, Salles GA, Horwitz SM, Vardhana SA, Perales MA, Schwartz D, Sereti I, Johnson WT.
Rocco JM, et al. Among authors: lim ms.
Blood. 2025 Dec 10:blood.2025030976. doi: 10.1182/blood.2025030976. Online ahead of print.
Blood. 2025.
PMID: 41369611